|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| IBC's Well Characterized Biologicals | ||||||||||||||||
| July 18, 2003 | ||||||||||||||||
|
IBC Life Sciences, Sheraton Premier at Tysons Corner, Vienna, VA November 12-14, 2003 IBC's 8th Well Characterized Biologicals conference continues to serve as a leading resource for industry representatives seeking updates on current analytical technologies and regulatory policies surrounding highly characterized biological therapeutics. The first presentation of the main conference is a rare keynote address on Immunogencity of Biological Therapeutics and Potential Approaches to Tolerance Induction by Amy Rosenberg, M.D., Director of the Division of Therapeutic Proteins, CDER, US, FDA. Your attendance will ensure comprehensive knowledge of the most recent changes in FDA perspectives. By attending Well Characterized Biologicals you will be able to implement vanguard techniques to obtain rapid possible approval of your biological. Benefit from the programming that will best meet your needs by adding on up for the short course on Immunogenicity. Reserve your space and register today. Detailed abstracts and registration information available are online at www.LifeSciencesInfo.com/WCB. |
||||||||||||||||
| Organized by: | IBC Life Sciences | |||||||||||||||
| Invited Speakers: | Keynote Speakers: Immunogenicity of Biological Therapeutics and Potential Approaches to Tolerance Induction |
|||||||||||||||
| Deadline for Abstracts: | - | |||||||||||||||
| Registration: | Phone: (508) 616-5550 x1004 Fax: (508) 616-5522 Email: reg@ibcusa.com Online: www.LifeSciencesInfo.com/WCB | |||||||||||||||
| E-mail: | reg@ibcusa.com | |||||||||||||||
| Posted by: | James G. Prudhomme | |||||||||||||||
| Host: | host-65-124-112-226.ibcusa.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||